Cas 1266533-88-3,2-(4,5-dihydro-1H-imidazol-2-yl)-6-(4-isobutyramidophenyl)-4,5-dihydropyridazin-3(2H)-one

1266533-88-3

Post Buying Request

Basic information

Product Name: 2-(4,5-dihydro-1H-imidazol-2-yl)-6-(4-isobutyramidophenyl)-4,5-dihydropyridazin-3(2H)-one
Synonyms:
CAS NO:1266533-88-3
Molecular Formula:
Molecular Weight: 327.386
EINECS: N/A
Product Categories: N/A
Mol File: 1266533-88-3.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-(4,5-dihydro-1H-imidazol-2-yl)-6-(4-isobutyramidophenyl)-4,5-dihydropyridazin-3(2H)-one(CAS DataBase Reference)
NIST Chemistry Reference: 2-(4,5-dihydro-1H-imidazol-2-yl)-6-(4-isobutyramidophenyl)-4,5-dihydropyridazin-3(2H)-one(1266533-88-3)
EPA Substance Registry System: 2-(4,5-dihydro-1H-imidazol-2-yl)-6-(4-isobutyramidophenyl)-4,5-dihydropyridazin-3(2H)-one(1266533-88-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1266533-88-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1266533-88-3 Suppliers

Recommended suppliersmore

1266533-88-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1266533-88-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,6,5,3 and 3 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1266533-88:
(9*1)+(8*2)+(7*6)+(6*6)+(5*5)+(4*3)+(3*3)+(2*8)+(1*8)=173
173 % 10 = 3
So 1266533-88-3 is a valid CAS Registry Number.

1266533-88-3Upstream product

1266533-88-3Downstream Products

1266533-88-3Relevant articles and documents

Synthesis and pharmacological evaluation of 6-arylpyridazinones as potent vasorelaxants

Bansal, Ranju,Kumar, Dinesh,Sharma, Deepika,Calle, Carmen,Carron, Rosalia

, p. 296 - 305 (2013/08/23)

Preclinical Research As part of a research program to identify compounds with potent antihypertensive properties, a new series of dihydropyridazin-3(2H)- one analogs was synthesized and evaluated for vasodilator activity in rat thoracic aortic rings. Most

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1266533-88-3